Connelly Robert's most recent trade in Elicio Therapeutics Inc. was a trade of 121,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc. | Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 121,600 | 121,600 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Robert Connelly | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 91,600 | 91,600 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc. | Connelly Robert | Director, CEO, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 225,137 | 225,137 | - | - | Stock Option (right to buy) |